Since high-concentrate thrombin preparations have excellent effectiveness for local hemostasis in patients with coagulopathies, the blood coagulation mechanism in the presence of high-concentrate thrombin, using purified thrombin, and plasminogen-f ree fibrinogen was investigated. The blood coagulation analyzer, CoagStat was utilized in the kinetic study of fibrin transformation. The first stage of fibrin precipitation speed was accelerated as the concentration increased and amounts of fibrin were gradually decreased in relation to the amount of sodium heparin given. The general result of this investigation was that anti-thrombin i and a large amount of heparin caused neutralization of dosages of 100 units/ ml thrombin with neutralization increasing with heparin dosage. In the investigation of thrombin diffusion, high-concentrate thrombin was diffused on an agarose plate, containing plasminogen-free fibrinogen, and was seen to precipitate an increasing amount of fibrin.
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From the result of this study, the accelerative function of thrombin in blood coagulation was confirmed again. High-concentrate thrombin penetrated and diffused into the fibrin network during scores of hours. We presume that this function brings about continual hemostatic efficacy. In a practical clinical application of thrombin, it seems that plasma inhibitor and released heparinoid affect the preparation.
From this experiment about 100 units/ml of thrombin was neutralized under AT-i and extra doses of heparin. Moreover, taking many kinds of plasma inhibitors into consideration, this approach showed that clinically more than 1000 units/ml thrombin was more effective. 16: 311
Fig. 1 Process of fibrin clot formation by various concentions of thrombin.
To 200 pl of prewarmed (37C, 3min) 0. 3% fibrinogen solution were added 100 pl of thrombin solution of various concentrations as indicated in Fig., and the fibrin polymerization was monitered with a blood coagulation analyzer, Coag-Stat. In (a), the abscissa indicates time and the ordinate indicates amout of fibrin polymerized. It was shown that the initial velocity of fibrin clot formation accelerated as the thrombin concentration increased. However, with 1, 000 units/ml thrombin the fibrin clot formation in the later stage did not increase as much as with 100 units/ml thrombin. In (b), the abscissa and ordinate are thrombin concentration and rate of fibrin formation, respectively, and ti-t5 indicate the same time points as in (a).
Although fibrin clot was formed explosively for the initial period until t1, the rate decreased as the time progressed thereafter. Fig. 2 Diffusion of thrombin in agarose gel. An aliquot of thrombin solutions of various concentrations was applied to the wells of a 0.65% agarose gel plate containing 0.3% fibrinogen, and the diffusion of thrombin was estimated by the area of fibrin-precipitated rings. It was demonstrated that the higher concentrations of thrombin led to the greater degrees of diffusion. When thrombin solutions of lower concentrations, 1 unit/ml or less, were tested, the diff ution was only a little.
